TGM1 and allergic respiratory disease: Additionally, soluble TGM1 protein administered intraperitoneally protects mice against both airway allergy [43] and inflammatory colitis [42], and in the latter model, oral administration of TGM1 also attenuated disease [46], although in the in vivo setting, TGF-β signalling is likely to activate multiple cell types in addition to Tregs.